These guidelines should be applied to patients with stable known or suspected coronary artery disease (SCAD).
The web addenda to the 2013 SCAD Guidelines contains additional material which should be used for further clarifications when reading the main document. The numbering of the chapters in this web document corresponds to the chapter numbering in the main document.EMA and ESC statements on ivabradine
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved